LAVAL, QC, Aug. 26 /CNW Telbec/ - This summer, cyclists who are taking
part in the Accu-Chek Cyclebetes to raise funds in support of research on
juvenile diabetes will be transiting through Laval on Friday, August 28. And
to mark this exceptional event, at 1:30 PM, Roche Diagnostics will be
welcoming to its Laval head office young Ambassadors of the cause living with
Type 1 diabetes, as well as members of the Juvenile Diabetes Research
Foundation (JDRF) and cyclists participating in the relay.
AudreyAnn, one of the young JDRF Ambassadors who will attend the event,
told us: "It is important to realize that even if a person has Type 1
diabetes, it is possible to strive to do more and better and to live life
fully. I dream that I will be cured someday and I feel this is within reach.
If there is enough money for research, I may be cured before I get old!".
The Accu-Chek Cyclebetes tour is a festival of cycling events held in
relay over a distance exceeding 10,000 km, from Nova Scotia to British
Columbia, between August 22 and September 13, 2009, with the aim of collecting
funds to support research on juvenile diabetes.
For the Accu-Chek Cyclebetes tour, provincial teams have been formed,
comprising of 5 duos -one adult and one youngster- pedaling in unison on a
tandem cycle. Most of the cyclists have Type 1 diabetes themselves or are
motivated by the fact that a family member has it.
Nathalie Dugas and her 8-year-old son Liam form one of the duos who have
accepted the challenge. Nathalie explains the reasons why they did. "Our whole
life changed drastically when Liam who was then 5 years old, was diagnosed
with Type 1 diabetes in February 2006. I want to do everything in my power so
that a cure is found for Liam and for all the persons affected by this
insidious disease. It is of the utmost importance for me to take part in the
world's biggest tandem-cycling relay with Liam to raise money for research, as
each dollar collected takes us a little bit closer to our dream!".
About Roche Diabetes Care
Roche Diabetes Care is a pioneer in the development of blood glucose
monitoring systems and a global leader for diabetes management systems and
services. For more than 30 years, the Accu-Chek brand has been committed to
enable people with diabetes to live life as normal and active as possible as
well as to help healthcare professionals manage their patients' condition in
an optimal way. Today, the Accu-Chek portfolio offers people with diabetes and
healthcare professionals innovative products and services and comprehensive
solutions for convenient, efficient and effective diabetes management spanning
from blood glucose monitoring through information management to insulin
delivery. The Accu-Chek brand encompasses blood glucose meters, infusion
pumps, lancing and data management systems.
For further information, please visit our websites
www.rochediagnostics.ca or www.accu-chek.ca.
Juvenile Diabetes Research Foundation (JDRF) is the leading charitable
funder and advocate of type 1 diabetes research worldwide. Our mission is to
find a cure for diabetes and its complications through the support of
research. JDRF has been fundamentally involved in the support and delivery of
diabetes research advances. Our resilience, passion and progress in research
towards a cure, as well as advancements in science and management tools has
improved the lives of children diagnosed with type 1 diabetes and the adults
living with this disease. Since its founding in 1970, JDRF has awarded more
than $1.3 billion to diabetes research, including more than $156 million in
2008. In 2008, the Foundation funded more than 1,000 centers, grants and
fellowships in 22 countries. For more information, please visit www.jdrf.ca.
All trademarks used or mentioned in this release are legally protected.
/NOTE TO PHOTO EDITORS: A photo accompanying this release is available on
the CNW Photo Network and archived at http://photos.newswire.ca.
Additional archived images are also available on the CNW Photo Archive
website at http://photos.newswire.ca. Images are free to accredited
members of the media/
For further information:
For further information: Michèle Beaubien, Communications, Roche
Diagnostics, (450) 686-5500, email@example.com; Dominique Quirion,
Communications, Juvenile Diabetes Research Foundation, (514) 744-5537 ext.